A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.

Martijn B A van Doorn; Jacobus Burggraaf; Tijtje van Dam; Anke Eerenberg; Marcel Levi; Cornelis E Hack; Rik C Schoemaker; Adam F Cohen; Jan Nuijens

doi:10.1016/j.jaci.2005.05.019

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.

Identifier:nobleid.org/w1/20260515/68417EEE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/68417EEE.svg?ark=w1%2F20260515%2F68417EEE)](https://nobleid.org/work/w1/20260515/68417EEE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Martijn B A van Doorn

Claim authorship of this work

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.

Identifier:nobleid.org/w1/20260515/68417EEE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/68417EEE.svg?ark=w1%2F20260515%2F68417EEE)](https://nobleid.org/work/w1/20260515/68417EEE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Martijn B A van Doorn

Claim authorship of this work